title: Intravitreal bevacizumab with regression of subretinal neovascularization after intraocular foreign body trauma.
authors.affiliation: Department of Ophthalmology, Chang Gung Memorial Hospital, Chang Gung University College of Medicine, Kwei-Shan, Taoyuan, Taiwan.
authors.forename: Tun-Lu
authors.initials: TL
authors.lastname: Chen
authors.forename: Ming-Hui
authors.initials: MH
authors.lastname: Sun
authors.forename: Ken-Kuo
authors.initials: KK
authors.lastname: Lin
authors.forename: Chi-Chun
authors.initials: CC
authors.lastname: Lai
authors.forename: Kuan-Jen
authors.initials: KJ
authors.lastname: Chen
mesh_terms: D020533:Angiogenesis Inhibitors / Q000008:administration & dosage*; D000911:Antibodies, Monoclonal / Q000008:administration & dosage*; D061067:Antibodies, Monoclonal, Humanized; D000068258:Bevacizumab; D015807:Eye Injuries, Penetrating / Q000000981:diagnostic imaging / Q000188:drug therapy* / Q000473:pathology; D005547:Foreign Bodies / Q000150:complications / Q000188:drug therapy* / Q000473:pathology; D006801:Humans; D056965:Injections, Intraocular; D008297:Male; D008875:Middle Aged; D011859:Radiography; D015861:Retinal Neovascularization / Q000188:drug therapy* / Q000209:etiology / Q000473:pathology; D014822:Vitreous Body
chemical_list: D020533:Angiogenesis Inhibitors; D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000068258:Bevacizumab